BACKGROUND: Primary anorectal melanoma is a rare and aggressive disease. It accounts for 0.5% of all rectal tumors. They are very agressive tumors with poor prognosis. The aim of this study is to report the clinical and evolutionary profile and therapeutical approach of these tumors. PATIENTS AND METHODS: A retrospective study of 17 patients with anorectal melanoma diagnosed between January 1998 and December 2007 was performed. The signs and symptoms, diagnostic study, and surgical and medical treatments were analyzed. RESULTS: The average age was 58 years. Sex ratio was 12 men per five women. Patients had symptoms present for an average of 6 months. The most common symptom was rectal bleeding. According to Slingluff classification, five patients had stage I (localized tumor), four cases had stage II (regional nodes metastasis), and eight cases had stage III (distant metastasis). Seven patients have radical surgery. Only two patients received adjuvant immunotherapy. Eight patients received palliative chemotherapy based on dacarbazine or cisplatinum. The median survival was 8 months. CONCLUSION: Prognosis of anorectal melanoma is still very poor. However, some patients when treated by radical resection may experience long-term survival. The use of adjuvant immunotherapy needs large collaborative studies in view of the rarity of the tumor.
BACKGROUND:Primary anorectal melanoma is a rare and aggressive disease. It accounts for 0.5% of all rectal tumors. They are very agressive tumors with poor prognosis. The aim of this study is to report the clinical and evolutionary profile and therapeutical approach of these tumors. PATIENTS AND METHODS: A retrospective study of 17 patients with anorectal melanoma diagnosed between January 1998 and December 2007 was performed. The signs and symptoms, diagnostic study, and surgical and medical treatments were analyzed. RESULTS: The average age was 58 years. Sex ratio was 12 men per five women. Patients had symptoms present for an average of 6 months. The most common symptom was rectal bleeding. According to Slingluff classification, five patients had stage I (localized tumor), four cases had stage II (regional nodes metastasis), and eight cases had stage III (distant metastasis). Seven patients have radical surgery. Only two patients received adjuvant immunotherapy. Eight patients received palliative chemotherapy based on dacarbazine or cisplatinum. The median survival was 8 months. CONCLUSION: Prognosis of anorectal melanoma is still very poor. However, some patients when treated by radical resection may experience long-term survival. The use of adjuvant immunotherapy needs large collaborative studies in view of the rarity of the tumor.
Authors: C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito Journal: J Clin Oncol Date: 2001-08-15 Impact factor: 44.544
Authors: Matthew T Ballo; Jeffrey E Gershenwald; Gunar K Zagars; Jeffrey E Lee; Paul F Mansfield; Eric A Strom; Agop Y Bedikian; Kevin B S Kim; Nicholas E Papadopoulos; Victor G Prieto; Merrick I Ross Journal: J Clin Oncol Date: 2002-12-01 Impact factor: 44.544
Authors: Kelli M Bullard; Todd M Tuttle; David A Rothenberger; Robert D Madoff; Nancy N Baxter; Charles O Finne; Michael P Spencer Journal: J Am Coll Surg Date: 2003-02 Impact factor: 6.113
Authors: Jen Jen Yeh; Jinru Shia; Wen Jen Hwu; Klaus J Busam; Philip B Paty; Jose G Guillem; Daniel G Coit; W Douglas Wong; Martin R Weiser Journal: Ann Surg Date: 2006-12 Impact factor: 12.969
Authors: Josh Bleicher; Jessica N Cohan; Lyen C Huang; William Peche; T Bartley Pickron; Courtney L Scaife; Tawnya L Bowles; John R Hyngstrom; Elliot A Asare Journal: World J Gastroenterol Date: 2021-01-21 Impact factor: 5.742
Authors: Won Young Chae; Jong Lyul Lee; Dong-Hyung Cho; Chang Sik Yu; Jin Roh; Jin Cheon Kim Journal: Cancer Res Treat Date: 2015-03-06 Impact factor: 4.679
Authors: Esther Jutten; Schelto Kruijff; Anne Brecht Francken; Martijn F Lutke Holzik; Barbara L van Leeuwen; Henderik L van Westreenen; Kevin P Wevers Journal: BJS Open Date: 2021-11-09